Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sleep Apnea Syndromes | 7 | 2019 | 282 | 2.94 | Why? |
| Polysomnography | 14 | 2019 | 296 | 1.97 | Why? |
| Deep Brain Stimulation | 4 | 2019 | 203 | 1.93 | Why? |
| REM Sleep Behavior Disorder | 3 | 2019 | 24 | 1.88 | Why? |
| Sleep Wake Disorders | 8 | 2019 | 1463 | 1.84 | Why? |
| Sleep, REM | 5 | 2018 | 46 | 1.81 | Why? |
| Ischemic Attack, Transient | 5 | 2019 | 439 | 1.77 | Why? |
| Stroke | 16 | 2019 | 8839 | 1.74 | Why? |
| Narcolepsy | 5 | 2018 | 80 | 1.73 | Why? |
| Sleep | 8 | 2019 | 2695 | 1.55 | Why? |
| Nocturnal Myoclonus Syndrome | 2 | 2018 | 10 | 1.46 | Why? |
| Electroencephalography | 6 | 2018 | 1242 | 1.28 | Why? |
| Orexins | 5 | 2018 | 21 | 1.17 | Why? |
| Parkinson Disease | 5 | 2019 | 1414 | 1.12 | Why? |
| Neurology | 7 | 2021 | 1613 | 1.06 | Why? |
| Brain Ischemia | 5 | 2019 | 2813 | 1.05 | Why? |
| Subthalamic Nucleus | 3 | 2019 | 36 | 1.02 | Why? |
| Parasomnias | 2 | 2017 | 2 | 0.91 | Why? |
| Somnambulism | 1 | 2017 | 1 | 0.74 | Why? |
| Sleep Stages | 1 | 2018 | 52 | 0.73 | Why? |
| Motor Skills | 1 | 2018 | 57 | 0.72 | Why? |
| Wakefulness-Promoting Agents | 1 | 2017 | 5 | 0.71 | Why? |
| Hypothalamic Hormones | 1 | 2017 | 2 | 0.70 | Why? |
| Pituitary Hormones | 1 | 2017 | 6 | 0.69 | Why? |
| Ischemic Preconditioning | 1 | 2017 | 43 | 0.68 | Why? |
| Autonomic Nervous System | 1 | 2019 | 148 | 0.68 | Why? |
| Cerebrovascular Disorders | 4 | 2019 | 1040 | 0.66 | Why? |
| Infarction, Middle Cerebral Artery | 2 | 2018 | 203 | 0.66 | Why? |
| Melanins | 1 | 2017 | 42 | 0.65 | Why? |
| Neurosciences | 1 | 2018 | 148 | 0.62 | Why? |
| Cerebral Cortex | 1 | 2018 | 276 | 0.60 | Why? |
| Corpus Callosum | 1 | 2018 | 182 | 0.60 | Why? |
| Sleep Deprivation | 1 | 2017 | 175 | 0.58 | Why? |
| Neurologists | 1 | 2018 | 283 | 0.57 | Why? |
| Movement Disorders | 1 | 2017 | 186 | 0.57 | Why? |
| Societies, Scientific | 1 | 2018 | 414 | 0.56 | Why? |
| Brain Injuries, Traumatic | 1 | 2016 | 381 | 0.45 | Why? |
| Rats, Sprague-Dawley | 3 | 2018 | 987 | 0.42 | Why? |
| Neuropeptides | 2 | 2017 | 91 | 0.42 | Why? |
| Sleep Apnea, Obstructive | 4 | 2019 | 668 | 0.40 | Why? |
| Continuous Positive Airway Pressure | 2 | 2018 | 1187 | 0.40 | Why? |
| Nervous System Diseases | 4 | 2021 | 4092 | 0.39 | Why? |
| Vascular Stiffness | 1 | 2013 | 264 | 0.39 | Why? |
| Brain Injuries | 3 | 2018 | 374 | 0.36 | Why? |
| Electromyography | 3 | 2018 | 278 | 0.34 | Why? |
| Wakefulness | 4 | 2018 | 598 | 0.31 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.28 | Why? |
| Quality of Life | 4 | 2019 | 9820 | 0.28 | Why? |
| Ischemia | 1 | 2013 | 901 | 0.28 | Why? |
| Lewy Body Disease | 1 | 2004 | 36 | 0.28 | Why? |
| Disorders of Excessive Somnolence | 1 | 2004 | 39 | 0.27 | Why? |
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 334 | 0.27 | Why? |
| Societies, Medical | 2 | 2018 | 6907 | 0.24 | Why? |
| Rats | 3 | 2018 | 2764 | 0.24 | Why? |
| Benzodiazepines | 2 | 2018 | 163 | 0.20 | Why? |
| GABA Antagonists | 1 | 2018 | 5 | 0.20 | Why? |
| Apathy | 1 | 2019 | 35 | 0.20 | Why? |
| Sleep Apnea, Central | 1 | 2019 | 28 | 0.19 | Why? |
| Humans | 52 | 2021 | 930598 | 0.19 | Why? |
| Vestibular Diseases | 1 | 2019 | 68 | 0.19 | Why? |
| Yawning | 1 | 2017 | 9 | 0.18 | Why? |
| Mental Status and Dementia Tests | 1 | 2019 | 208 | 0.18 | Why? |
| Cheyne-Stokes Respiration | 1 | 1997 | 5 | 0.18 | Why? |
| Psychomotor Agitation | 1 | 2020 | 208 | 0.18 | Why? |
| Oxazoles | 1 | 2018 | 75 | 0.18 | Why? |
| Headache | 2 | 2020 | 2257 | 0.18 | Why? |
| Sodium Oxybate | 1 | 2017 | 14 | 0.18 | Why? |
| Essential Tremor | 1 | 2017 | 19 | 0.18 | Why? |
| Cataplexy | 1 | 2017 | 9 | 0.18 | Why? |
| Brain Chemistry | 1 | 2017 | 49 | 0.18 | Why? |
| Recovery of Function | 2 | 2018 | 2461 | 0.18 | Why? |
| Agnosia | 1 | 2017 | 12 | 0.17 | Why? |
| Venlafaxine Hydrochloride | 1 | 2017 | 30 | 0.17 | Why? |
| Cognition Disorders | 2 | 2017 | 574 | 0.17 | Why? |
| Europe | 5 | 2021 | 12702 | 0.17 | Why? |
| Diagnostic Techniques, Neurological | 1 | 2017 | 46 | 0.17 | Why? |
| Actigraphy | 1 | 2017 | 102 | 0.17 | Why? |
| Restless Legs Syndrome | 1 | 2017 | 53 | 0.17 | Why? |
| Visual Perception | 1 | 2017 | 49 | 0.17 | Why? |
| Dizziness | 1 | 2019 | 275 | 0.17 | Why? |
| Cerebellar Diseases | 1 | 1997 | 90 | 0.16 | Why? |
| White Matter | 2 | 2017 | 369 | 0.16 | Why? |
| Supervised Machine Learning | 1 | 2018 | 172 | 0.16 | Why? |
| Neural Pathways | 1 | 2017 | 155 | 0.16 | Why? |
| Ataxia | 1 | 2017 | 133 | 0.16 | Why? |
| Autoantigens | 1 | 2018 | 388 | 0.15 | Why? |
| Sleep Initiation and Maintenance Disorders | 2 | 2018 | 1692 | 0.15 | Why? |
| Male | 26 | 2021 | 367725 | 0.15 | Why? |
| Neurons | 2 | 2018 | 864 | 0.15 | Why? |
| Chi-Square Distribution | 1 | 2018 | 961 | 0.14 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.14 | Why? |
| Rare Diseases | 1 | 2018 | 373 | 0.14 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.13 | Why? |
| Benzhydryl Compounds | 1 | 2017 | 240 | 0.13 | Why? |
| Aged | 15 | 2021 | 215776 | 0.13 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.13 | Why? |
| Female | 24 | 2021 | 380317 | 0.13 | Why? |
| Prospective Studies | 5 | 2019 | 43301 | 0.12 | Why? |
| Circadian Rhythm | 1 | 2019 | 607 | 0.12 | Why? |
| Psychiatric Status Rating Scales | 1 | 2019 | 1340 | 0.12 | Why? |
| Off-Label Use | 1 | 2017 | 553 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.12 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.11 | Why? |
| Adult | 18 | 2021 | 244371 | 0.11 | Why? |
| Physical Examination | 1 | 2017 | 755 | 0.11 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.11 | Why? |
| Animals | 7 | 2018 | 78931 | 0.11 | Why? |
| Activities of Daily Living | 1 | 2019 | 1530 | 0.11 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.10 | Why? |
| Autoimmune Diseases | 2 | 2021 | 1996 | 0.10 | Why? |
| Switzerland | 1 | 2018 | 2738 | 0.10 | Why? |
| Muscle, Skeletal | 1 | 2017 | 915 | 0.10 | Why? |
| Health Surveys | 2 | 2020 | 2841 | 0.10 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.10 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.09 | Why? |
| Immunotherapy | 1 | 2021 | 2421 | 0.09 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.08 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.08 | Why? |
| Prognosis | 3 | 2017 | 32490 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Radioimmunoassay | 1 | 2004 | 25 | 0.07 | Why? |
| Echo-Planar Imaging | 1 | 2003 | 27 | 0.07 | Why? |
| Spinal Cord Ischemia | 1 | 2003 | 30 | 0.07 | Why? |
| Brain | 2 | 2018 | 5133 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.06 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Multiple Sclerosis | 1 | 2018 | 2600 | 0.06 | Why? |
| Diclofenac | 1 | 2001 | 27 | 0.06 | Why? |
| Endothelium, Vascular | 1 | 2013 | 1751 | 0.06 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.05 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2003 | 317 | 0.05 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Risk | 1 | 2013 | 5288 | 0.05 | Why? |
| Emergency Medical Services | 1 | 2017 | 3557 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Periodontal Diseases | 1 | 2001 | 87 | 0.05 | Why? |
| Body Mass Index | 1 | 2013 | 4306 | 0.05 | Why? |
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2018 | 3 | 0.05 | Why? |
| Receptors, GABA-A | 1 | 2018 | 15 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Oxygen | 1 | 2013 | 3715 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Sleep Latency | 1 | 2018 | 33 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Vertigo | 1 | 2019 | 141 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Neuroprotection | 1 | 2018 | 62 | 0.05 | Why? |
| Mouth Diseases | 1 | 2001 | 193 | 0.04 | Why? |
| Neuronal Plasticity | 1 | 2018 | 98 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Chin | 1 | 2017 | 14 | 0.04 | Why? |
| Muscle Hypotonia | 1 | 2017 | 16 | 0.04 | Why? |
| Neurotransmitter Agents | 1 | 2017 | 57 | 0.04 | Why? |
| Thalamus | 1 | 2017 | 75 | 0.04 | Why? |
| Emergency Service, Hospital | 2 | 2019 | 14232 | 0.04 | Why? |
| Diffusion Tensor Imaging | 1 | 2017 | 125 | 0.04 | Why? |
| Pupil | 1 | 1996 | 22 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
| Serotonin | 1 | 2017 | 137 | 0.04 | Why? |
| Cell Separation | 1 | 2018 | 270 | 0.04 | Why? |
| Mouthwashes | 1 | 2001 | 432 | 0.04 | Why? |
| Stochastic Processes | 1 | 2018 | 369 | 0.04 | Why? |
| Aphasia | 1 | 1996 | 33 | 0.04 | Why? |
| Eye Movements | 1 | 1996 | 41 | 0.04 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 694 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Histamine Antagonists | 1 | 2017 | 203 | 0.04 | Why? |
| Delphi Technique | 1 | 2020 | 1257 | 0.04 | Why? |
| Phototherapy | 1 | 2017 | 138 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Depression | 1 | 2019 | 14116 | 0.04 | Why? |
| Visual Fields | 1 | 1996 | 123 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Neck | 1 | 2017 | 307 | 0.03 | Why? |
| Cranial Nerve Diseases | 1 | 1996 | 148 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Peripheral Nervous System Diseases | 1 | 1996 | 193 | 0.03 | Why? |
| Complementary Therapies | 1 | 2017 | 280 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2021 | 1276 | 0.03 | Why? |
| Primary Prevention | 1 | 2021 | 778 | 0.03 | Why? |
| Interpersonal Relations | 1 | 2021 | 926 | 0.03 | Why? |
| Cerebral Infarction | 1 | 1996 | 245 | 0.03 | Why? |
| Cerebrovascular Circulation | 1 | 1996 | 340 | 0.03 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.03 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Antidepressive Agents | 1 | 2017 | 509 | 0.03 | Why? |
| Respiration | 1 | 1997 | 729 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 1454 | 0.03 | Why? |
| Datasets as Topic | 1 | 2018 | 1404 | 0.03 | Why? |
| Autoimmunity | 1 | 2018 | 841 | 0.03 | Why? |
| Syndrome | 1 | 1996 | 1310 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2019 | 48226 | 0.03 | Why? |
| Melatonin | 1 | 2017 | 578 | 0.03 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Orthomyxoviridae | 1 | 2018 | 1168 | 0.02 | Why? |
| Acute Disease | 2 | 2003 | 6029 | 0.02 | Why? |
| Antipsychotic Agents | 1 | 2017 | 887 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Cross Reactions | 1 | 2018 | 4374 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Immunologic Memory | 1 | 2018 | 3362 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.02 | Why? |
| Comorbidity | 2 | 2018 | 34796 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Postoperative Complications | 1 | 2001 | 5861 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2018 | 5837 | 0.01 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
Bassetti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(229)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(87)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_